期刊文献+

鼠胚胎干细胞及其衍生神经前体细胞的免疫原性检测 被引量:2

Immunogenicity of Mouse Embryonic Stem Cells and Derived Neural Progenitor Cells
下载PDF
导出
摘要 目的:体外观察ES-D3鼠胚胎干细胞(mESCs)及其衍生神经前体细胞(NPCs)的免疫原性。方法:采用无血清培养法从mESCs诱导出NPCs,运用流式细胞仪检测mESCs及NPCs主要组织相容性复合物(MHC)Ⅰ、Ⅱ类分子的组成型表达,及γ干扰素(IFN-γ)诱导作用下MHC分子诱导型表达情况。结果:mESCs在未分化前少量表达MHC-Ⅰ分子但几乎无MHC-Ⅱ分子表达,经诱导分化成NPCs后MHC-Ⅰ分子表达明显上调但MHC-Ⅱ分子仅微弱增加;运用IFN-γ诱导ESCs及NPCs,二者MHC-Ⅰ分子表达进一步增加,而NPCs MHC-Ⅱ分子也呈现相当程度上调。结论:ESCs及其衍生的NPCs具有一定免疫原性,体内移植之后可能引起针对MHC Ⅰ类或Ⅱ类抗原的移植排斥。 Objective:To study the immunogenicity of embryonic stem cells(ESCs)and derived neural progenitor cells(NPCs) in vitro.Methods: By cultured in serum free selective medium,ES-D3 ESCs were induced into NPCs.The constructive expression of major histocompatibility complex(MHC) class I and II on ESCs and NPCs was evaluated by flow cytometry(FCM) and the inducible expression of MHC-I and II was investigated after IFN-γ induction.Results: ES-D3 ESCs expressed low level MHC-I but no MHC-II molecules.After differentiation the expression of MHC-I on NPCs had a significant up-regulation but MHC-II molecules showed no change.However,when treatment with IFN-γ the ESCs and NPCs demonstrated further moderately increased MHC-I molecules whereas a slight but measurable up-regulation of MHC-II was present on NPCs surfaces.Conclusion: ESCs and their derived NPCs may evoke a possible immune response directed to MHC-I or II molecules on their surfaces.
出处 《神经损伤与功能重建》 2008年第5期307-309,共3页 Neural Injury and Functional Reconstruction
关键词 胚胎干细胞 神经前体细胞 免疫原性 embryonic stem cells neural precursor cells immunogenicity
  • 相关文献

参考文献4

  • 1Okabe S, Forsberg-Nilsson K, Spiro AC, et al. Development of Neuronal Precursor Cells and Functional Potmitotic Neurons from Embryonic Stem Cells in Vitro [J]. Mech Dev(S0925-4773), 1996,59 : 89 - 102.
  • 2Draper JS, Pigott C, Thomson JA, et al. Surface Antigens of Human Embryonic Stem Cells: Changes Upon Differentiation in Culture [J]. J Anat (S0021- 8782), 2002,200:249 - 258.
  • 3Swijnenburg RJ, Tanaka M, Vogel H, et al. Embryonic Stem Cell Immunogenieity Increases Upon Differentiation After Transplantation into Ischemic Myoear- dium[J]. Circulation (S0009 - 7322), 2005, 112 (suppl 1) :166-172.
  • 4Shamblott MJ, Axelman J, Littlefield JW, et al. Human Embryonic Germ Cell Derivatives Express a Broad Range of Developmentally Distinct Markers and Proliferate Extensively in Vitro [J]. Prac Natl Acad Sci U S A(S0027-8424), 2001, 98: 113-118.

同被引文献16

  • 1Francesco Bifari,Luciano Pacelli,Mauro Krampera.Immunological properties of embryonic and adult stem cells[J].World Journal of Stem Cells,2010,2(3):50-60. 被引量:2
  • 2Manicassamy S and Pulendran B. Dendritic cell control oftolerogenic responses [ J]. Immunol Rev,2011,241 ( 1 ) :206-227.
  • 3Johansson S, Price J and Modo M. Effect of inflammatory eytokines on major histoeompatibility complex expression and differentiation of human neural stem/progenitor eells[ J]. Stem Cells,2008,26 : 2444-2454.
  • 4Fairchild PJ, Nolan KF, Cartland S. Embryonic stem cells:a novel source of dendritic cells for clinical applications [ J ]. Int Immunop- hannaco1,2005,5 : 13-21.
  • 5Moreau A, Varey E, B6riou G, et al. Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials [ J]. Front Immunol,2012 ,3 :218.
  • 6WalshPT, Taylor DK, Turka LA. Tregs and transplantation tolerance [ J]. J Clin Invest,2004,114 : 1398-1403.
  • 7Waldmann H, Cobbold S. Regulating the immune response to transplants:a role for CD4 regulatory cells.'? [J]. Immunity, 2001,14:399-406.
  • 8Jonuleit H, Schmitt E, Schuler G, et al. Induction of intedeukin 10-producing, nonproliferating CD4 T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells [ J ]. J Exp Med ,2000,192 : 1213-1222.
  • 9Levings MK, Greg0ri S, Tresoldi E, et al. Differentiation of Trl cells by immature dendritic cells requires IL-10 but not CD25 CD4 Tr cells [J]. Blood,2005,105:1162-1169.
  • 10Wang Z, Divito S J, Shufesky WJ,et al. Dendritic cell therapies in transplantation revisited: deletion of recipient DCs deters the effect of therapeutic DCs [ J ]. Am J Transplant, 2012,12 ( 6 ) : 1398-1408.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部